Enovix Puts Eyewear Ahead Of Smartphones And Forecasts $65 Million To $85 Million Sales
The 2027 outlook exceeds its 2026 revenue estimate, but fourth-quarter sales are expected to fall from a year earlier.
Enovix, which makes lithium-ion batteries for drones and smart eyewear, halted smartphone field-testing plans and projected $65 million–$85 million in 2027 sales Thursday. Its SEC filing and accompanying results release put that outlook against a 2026 revenue estimate of $36.7 million–$37.7 million, with silicon-anode development shifting toward eyewear.
Smartphone Testing Hits An Energy Limit
Enovix's smartphone cells passed internal qualification, but the process used failed to reach its latest target of more than 1,000 watt-hours per liter. The company abandoned system-level field testing with those cells; it expects its lead phone customer's parallel qualification to finish next week.
Future energy-density improvements will go first to customers among its 24 smart-eyewear accounts. Eyewear shipments have reached approximately 19,000 units this year against a 50,000-pack backlog that Enovix plans to complete in the first half of 2027.
Interim CEO Ryan Benton described the new sales forecast as having “with nearly half the midpoint already in backlog.”
The outlook follows Enovix's October rejection of an unauthorized estimate published by The Electric: around $100 million in 2027 revenue, predominantly from smartphones. Enovix told investors not to rely on it as guidance.
Drone Orders Meet A Softer Quarter
Drone business added an initial order for 100,000 conventional batteries from a multinational dual-use systems provider. A U.S. drone manufacturer placed an initial production order for higher-energy MX1-B01 aerial-drone cells after successful field trials, with first deliveries scheduled for early 2027.
Enovix makes conventional graphite and silicon-blended graphite cells in South Korea for drone applications spanning aerial, underwater and ground vehicles. Its drone, defense and industrial opportunities reached approximately $216 million, up 18% from $183 million in the prior quarter; drones accounted for $150 million. These prospects are not committed sales, and orders in backlog can be changed or canceled.
Unaudited third-quarter sales rose 38% from a year earlier to $11.0 million, also up 22% from the second quarter. Enovix attributed growth to drone and defense customers. Adjusted gross margin reached 34.5%, versus 21.0%, which the company credited to its mix of eyewear, drone and defense sales.
The net loss attributable to Enovix narrowed to $41.9 million from $53.7 million, while the adjusted loss widened to $31.9 million from $29.2 million. Management expects fourth-quarter revenue of $9.0 million–$10.0 million, below last year's $11.3 million, and an adjusted operating loss of $28.0 million–$31.0 million.
Korea Gains Resources, Debt Shrinks
Last Thursday, Enovix announced approximately 220 cuts to employee and contract-labor positions, redirecting staffing and capital toward South Korea while reducing costs in the U.S., India and Malaysia. It expects approximately $8.5 million in annual savings.
Quarter-end cash and investments, including restricted cash, totaled $512.2 million before subsequent debt and stock repurchases. Enovix retired $128.0 million of notes due in 2030 for approximately $81.4 million, capturing a $46.6 million discount and leaving $232.0 million outstanding. It bought back $6.2 million of stock during the quarter and another $15.5 million in October.
Enovix expects its $19 million South Korean expansion to double drone-battery capacity and begin operating in the second quarter of 2027.
Sources
- 8-K Filing — Enovix Corp (ENVX) — SEC EDGAR
- Exhibit enovixq32026financialres.htm — Enovix Corp 8-K exhibit — SEC EDGAR
- 8-K filed 2026-11-05 — Enovix Corp (earlier disclosure) — SEC EDGAR
- 8-K filed 2026-10-22 — Enovix Corp (earlier disclosure) — SEC EDGAR